| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.073 | 0.08 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |